{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:14:57Z","timestamp":1788365697708,"version":"build-2803163510"},"reference-count":11,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymthe.2026.08.015","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:57:18Z","timestamp":1787925438000},"page":"5045-5046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancing variant agnostic liver-directed gene editing using homology-independent targeted integration"],"prefix":"10.1016","volume":"34","author":[{"given":"Michael A.","family":"Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9146-3112","authenticated-orcid":false,"given":"Cary O.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.08.015_bib1","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1016\/j.ymthe.2026.06.044","article-title":"Functional editing of the OTC locus by targeted integration with phenotype correction and restoration of endogenous expression patterns","volume":"34","author":"Ginn","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.015_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.952467","article-title":"Pathogenic variants of ornithine transcarbamylase deficiency: Nation-wide study in Japan and literature review","volume":"13","author":"Kido","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymthe.2026.08.015_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.877","article-title":"Glycogen storage diseases: Twenty-seven new variants in a cohort of 125 patients","volume":"7","author":"Sperb-Ludwig","year":"2019","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.ymthe.2026.08.015_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108514","article-title":"Significance of utilizing in silico structural analysis and phenotypic data to characterize phenylalanine hydroxylase variants: A PAH landscape","volume":"142","author":"Himmelreich","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2026.08.015_bib5","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/mt.2009.88","article-title":"AAV2\/8-mediated correction of OTC deficiency is robust in adult but not neonatal Spf(ash) mice","volume":"17","author":"Cunningham","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.015_bib6","article-title":"A mutation-independent CRISPR-Cas9-mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency","volume":"6","author":"Wang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.08.015_bib7","article-title":"Functional Characterization of the spf\/ash Splicing Variation in OTC Deficiency of Mice and Man","volume":"10","author":"Rivera-Barahona","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2026.08.015_bib8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nbt.3469","article-title":"A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice","volume":"34","author":"Yang","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.015_bib9","article-title":"Efficient in vivo editing of OTC-deficient patient-derived primary human hepatocytes","volume":"2","author":"Ginn","year":"2020","journal-title":"JHEP Rep."},{"key":"10.1016\/j.ymthe.2026.08.015_bib10","article-title":"P008: A first in human, single arm, open label phase 1\/2 study evaluating ECUR-506 in neonatal OTC Deficiency: Initial Observations","volume":"3","author":"Baruteau","year":"2025","journal-title":"Genet. Med. Open"},{"key":"10.1016\/j.ymthe.2026.08.015_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ymthe.2024.11.032","article-title":"Amelioration of metabolic and behavioral defects through base editing in the PahR408W phenylketonuria mouse model","volume":"33","author":"Yin","year":"2025","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:19:06Z","timestamp":1788362346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626006970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1525001626006970"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.015","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing variant agnostic liver-directed gene editing using homology-independent targeted integration","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}